RE: Results RNS14 Sep 2022 09:29
Rock solid numbers, but CAML had nearly everything going its way in H1. Lower interest charges and treatment costs, higher metal prices, foreign currency benefitting their cost base and no $5m hedging charge as in H1 21. The second half sees the company with its finances in robust shape, but metal prices have dipped sharply and costs and capex will show a large increase for H2.